000 01210 a2200337 4500
005 20250513035413.0
264 0 _c19951003
008 199510s 0 0 eng d
022 _a0305-7372
024 7 _a10.1016/0305-7372(95)90001-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLowenthal, E A
245 0 0 _aThe use of anthracyclines in the adjuvant treatment of breast cancer.
_h[electronic resource]
260 _bCancer treatment reviews
_cMay 1995
300 _a199-214 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntibiotics, Antineoplastic
_xpharmacology
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aDisease-Free Survival
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Resistance
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLymphatic Metastasis
650 0 4 _aSurvival Rate
700 1 _aCarpenter, J T
773 0 _tCancer treatment reviews
_gvol. 21
_gno. 3
_gp. 199-214
856 4 0 _uhttps://doi.org/10.1016/0305-7372(95)90001-2
_zAvailable from publisher's website
999 _c7655696
_d7655696